- Report
- October 2022
- 117 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- December 2021
- 111 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- August 2021
- 122 Pages
Global
From €4295EUR$4,450USD£3,684GBP
- Report
- March 2018
- 69 Pages
Global
From €3957EUR$4,100USD£3,395GBP
- Report
- January 2022
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- December 2021
- 48 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- October 2021
- 166 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- October 2021
- 260 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- November 2020
Global
From €7239EUR$7,500USD£6,210GBP
From €3378EUR$3,500USD£2,898GBP
- Report
- May 2023
- 89 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2018
- 120 Pages
Global
From €578EUR$599USD£496GBP
- Report
- February 2024
- 150 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2024
- 197 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2024
- 186 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- March 2022
- 236 Pages
Global
From €5568EUR$5,769USD£4,776GBP
- Report
- February 2024
- 160 Pages
Global
From €5308EUR$5,499USD£4,553GBP
- Report
- October 2023
- 140 Pages
Global
From €2895EUR$2,999USD£2,483GBP
- Report
- May 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Bare Metal Stent (BMS) market is a subset of the larger stent market. BMS are medical devices used to treat narrowed or blocked arteries. They are made of stainless steel or cobalt chromium and are designed to be inserted into the artery to keep it open. BMS are used to treat a variety of conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. BMS are typically used in combination with other treatments, such as angioplasty or bypass surgery.
BMS are considered to be a cost-effective treatment option for many patients, as they are less expensive than other stent types. They are also less invasive than other treatments, making them a popular choice for many patients.
Some of the major companies in the BMS market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more